Linggui Zhugan decoction delays ventricular remodeling in rats with chronic heart failure after myocardial infarction through the Wnt/β-catenin signaling pathway

被引:12
|
作者
Yang, Mingming [1 ]
Wu, Haiyan [1 ]
Qian, Hang [1 ]
Li, Dongfeng [1 ]
Xu, Hao [1 ]
Chen, Jishun [1 ]
Zhong, Jixin [3 ]
Wu, Wenwen [4 ]
Yang, Handong [1 ]
Chen, Xinlong [2 ]
Min, Xinwen [1 ]
Chen, Jun [1 ]
机构
[1] Hubei Univ Med, Sinopharm Dongfeng Gen Hosp, Hubei Clin Res Ctr Hypertens, Hubei Key Lab Wudang Local Chinese Med Res, Shiyan, Peoples R China
[2] Yunxi Hosp Chinese Med, Shiyan, Hubei, Peoples R China
[3] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Rheumatol & Immunol, Wuhan 430030, Hubei, Peoples R China
[4] Hubei Univ Med, Sch Publ Hlth, Shiyan, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
Animal experiments; Heart failure; Myocardial infarction; Traditional Chinese Medicine; Ventricular remodeling; FRAGMENT; ST2;
D O I
10.1016/j.phymed.2023.155026
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Context: Traditional Chinese medicine plays an important role in the prevention and treatment of heart failure (HF). Linggui Zhugan decoction has been approved for clinical treatment of chronic HF. However, the mechanism is still unclear. Objective: The effect of Linggui Zhugan decoction on the Wnt/beta-catenin signaling pathway in rat myocardium was studied to investigate the mechanism by Linggui Zhugan decoction effects ventricular remodeling in rats with heart failure after myocardial infarction. Method: A rat model of HF after myocardial infarction was prepared by ligating the left anterior descending coronary artery. After 6 weeks of intervention with Linggui Zhugan decoction, the effect of Linggui Zhugan decoction on the cardiac function of chronic HF model rats was observed. Myocardial infarct size was measured by triphenyl tetrazolium chloride (TTC) staining. Enzyme linked immunosorbent assays (ELISAs) were used to measure NT-proBNP and sST-2 concentrations in rat serum. Hematoxylin and eosin (H&E) staining, and Masson's trichrome staining were used to observe the morphology of myocardial tissue; immunohistochemistry was used to detect the protein expression of type I collagen and type III collagen in myocardial tissue; and mRNA expression levels of Wnt3a, GSK-3 beta, beta-catenin, and c-Myc in the infarct marginal zone were detected using PCR. Protein expression of Wnt3a, p-GSK-3 beta, GSK-3 beta, and beta-catenin in the infarct marginal zone was detected using western blot. Results: Compared with the control, Linggui Zhugan decoction reduced the levels of serum ST-2 and NT-proBNP, improved cardiac function, and reduced the deposition of collagen fiber. In addition, Linggui Zhugan decoction inhibited the expression of Wnt3a, p-GSK-3 beta, and beta-catenin in cardiomyocytes. Conclusion: Linggui Zhugan decoction inhibits the expression of several key proteins in the Wnt/beta-catenin signaling pathway, delays cardiomyocyte hypertrophy and fibrosis, and improves cardiac function.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Linggui Zhugan Decoction (sic) Inhibits Ventricular Remodeling after Acute Myocardial Infarction in Mice by Suppressing TGF-β1/Smad Signaling Pathway
    Wang Liang
    Shi Hui
    Huang Jin-ling
    Xu Shan
    Liu Pei-pei
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2020, 26 (05) : 345 - 352
  • [2] Modified Linggui Zhugan Decoction protects against ventricular remodeling through ameliorating mitochondrial damage in post-myocardial infarction rats
    Xiang, Mi
    Zhao, Xin
    Lu, Yingdong
    Zhang, Yang
    Ding, Fan
    Lv, Lifei
    Wang, Yuling
    Shen, Zihuan
    Li, Li
    Cui, Xiangning
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 9
  • [3] Linggui Zhugan Decoction(苓桂术甘汤) Inhibits Ventricular Remodeling after Acute Myocardial Infarction in Rats by Suppressing TGF-β1/Smad Signaling Pathway
    WANG Liang
    SHI Hui
    HUANG Jinling
    XU Shan
    LIU Peipei
    Chinese Journal of Integrative Medicine, 2020, (05) : 345 - 352
  • [4] Linggui Zhugan Decoction(苓桂术甘汤) Inhibits Ventricular Remodeling after Acute Myocardial Infarction in Rats by Suppressing TGF-β1/Smad Signaling Pathway
    WANG Liang
    SHI Hui
    HUANG Jinling
    XU Shan
    LIU Peipei
    Chinese Journal of Integrative Medicine, 2020, 26 (05) : 345 - 352
  • [5] Linggui Zhugan Decoction (苓桂术甘汤) Inhibits Ventricular Remodeling after Acute Myocardial Infarction in Rats by Suppressing TGF-β1/Smad Signaling Pathway
    Liang Wang
    Hui Shi
    Jin-ling Huang
    Shan Xu
    Pei-pei Liu
    Chinese Journal of Integrative Medicine, 2020, 26 : 345 - 352
  • [6] Linggui Zhugan Decoction activates the SIRT1-AMPK-PGC1α signaling pathway to improve mitochondrial and oxidative damage in rats with chronic heart failure caused by myocardial infarction
    Yu, Siyi
    Qian, Hang
    Tian, Dawei
    Yang, Mingming
    Li, Dongfeng
    Xu, Hao
    Chen, Jishun
    Yang, Jingning
    Hao, Xincai
    Liu, Zhixin
    Zhong, Jixin
    Yang, Handong
    Chen, Xinlong
    Min, Xinwen
    Chen, Jun
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [7] Transcription factor EB (TFEB) improves ventricular remodeling after myocardial infarction by inhibiting Wnt/β-catenin signaling pathway
    Liu, Cong
    Zhou, Dawang
    Zhang, Qiang
    Wei, Hongyan
    Lu, Yuanzheng
    Li, Bo
    Zhan, Haohong
    Cheng, Jingge
    Wang, Chuyue
    Yang, Yilin
    Li, Shuhao
    Hu, Chunlin
    Liao, Xiaoxing
    PEERJ, 2023, 11
  • [8] Sclerostin aggravates cardiac remodeling after myocardial infarction by inhibition of Wnt/β-catenin signaling pathway
    Zheng, Shuxin
    Wei, Jinyi
    Chen, Peipei
    Chen, Fangliang
    Yang, Guang
    JOURNAL OF THORACIC DISEASE, 2022, 14 (05) : 1563 - +
  • [9] MiR-34a regulates cell apoptosis after myocardial infarction in rats through the Wnt/β-catenin signaling pathway
    Li, J-H
    Dai, J.
    Han, B.
    Wu, G-H
    Wang, C-H
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (06) : 2555 - 2562
  • [10] Influence of MiR-154 on myocardial apoptosis in rats with acute myocardial infarction through Wnt/β-catenin signaling pathway
    Sun, H-Y
    Wang, X-L
    Ma, L-C
    Yang, M.
    Yang, H-J
    Huang, H-W
    Zhao, G-A
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (02) : 818 - 825